FiercePharma

Gilead’s stealing hep C share with its cut-rate Eplusa and Harvoni generics

Last September, Gilead made the unexpected move of launching authorized generics to its blockbuster hepatitis C drugs Epclusa and Harvoni, well before their patients expire. Now the copycats have ...
Hackaday

Writing Type-Safe Generics In C

The fun part about a programming language like C is that although the language doesn’t directly support many features including object-oriented programming and generics, there’s nothing that’s keeping ...
FiercePharma

Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway

Gilead Sciences isn't letting a few of its own generics interfere with advertising its pan-genotypic hep C drug Epclusa. The Big Biotech is turning to TV again to promote its hep C franchise, this ...
Fierce Healthcare

OIG: Part D plans sidestepped cheaper hep C generics for pricey brand-name versions

Some Medicare Part D plans did not cover generic versions of pricey hepatitis C drugs in 2019, leaving millions in savings on the table, according to a new watchdog report. The report, released ...
Hosted on MSN

Generics a commonsense answer to high drug prices

Drug makers spent $104 billion on research and development in 2024 for drugs that Americans who need them may never be able to afford. That investment is wasted when patients are priced out of ...